🇺🇸 FDA
Patent

US 11345702

PGDH inhibitors and methods of making and using

granted A61KA61K31/4184A61K31/437

Quick answer

US patent 11345702 (PGDH inhibitors and methods of making and using) held by Myoforte Therapeutics, Inc. expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Myoforte Therapeutics, Inc.
Grant date
Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/4184, A61K31/437, A61K31/4453, A61K31/454